156 related articles for article (PubMed ID: 20305496)
1. Firefly luciferase-based dynamic bioluminescence imaging: a noninvasive technique to assess tumor angiogenesis.
Sun A; Hou L; Prugpichailers T; Dunkel J; Kalani MA; Chen X; Kalani MY; Tse V
Neurosurgery; 2010 Apr; 66(4):751-7; discussion 757. PubMed ID: 20305496
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive bioluminescence imaging of luciferase expressing intracranial U87 xenografts: correlation with magnetic resonance imaging determined tumor volume and longitudinal use in assessing tumor growth and antiangiogenic treatment effect.
Szentirmai O; Baker CH; Lin N; Szucs S; Takahashi M; Kiryu S; Kung AL; Mulligan RC; Carter BS
Neurosurgery; 2006 Feb; 58(2):365-72; discussion 365-72. PubMed ID: 16462491
[TBL] [Abstract][Full Text] [Related]
3. The temporal correlation of dynamic contrast-enhanced magnetic resonance imaging with tumor angiogenesis in a murine glioblastoma model.
Veeravagu A; Hou LC; Hsu AR; Cai W; Greve JM; Chen X; Tse V
Neurol Res; 2008 Nov; 30(9):952-9. PubMed ID: 18662497
[TBL] [Abstract][Full Text] [Related]
4. Longitudinal bioluminescence imaging of the dynamics of Doxorubicin induced apoptosis.
Niu G; Zhu L; Ho DN; Zhang F; Gao H; Quan Q; Hida N; Ozawa T; Liu G; Chen X
Theranostics; 2013; 3(3):190-200. PubMed ID: 23471295
[TBL] [Abstract][Full Text] [Related]
5. A novel rat model for glioblastoma multiforme using a bioluminescent F98 cell line.
Bryant MJ; Chuah TL; Luff J; Lavin MF; Walker DG
J Clin Neurosci; 2008 May; 15(5):545-51. PubMed ID: 18378459
[TBL] [Abstract][Full Text] [Related]
6. In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in an orthotopic glioblastoma model.
Hsu AR; Hou LC; Veeravagu A; Greve JM; Vogel H; Tse V; Chen X
Mol Imaging Biol; 2006; 8(6):315-23. PubMed ID: 17053862
[TBL] [Abstract][Full Text] [Related]
7. Molecular Imaging of Tumor Progression and Angiogenesis by Dual Bioluminescence.
Liu Y; Huang Z; Li Z
Methods Mol Biol; 2022; 2524():457-469. PubMed ID: 35821492
[TBL] [Abstract][Full Text] [Related]
8. Using bioluminescence to image gene expression and spontaneous behavior in freely moving mice.
Malik A; Zavadil JA; Geusz ME
PLoS One; 2023; 18(1):e0279875. PubMed ID: 36662734
[TBL] [Abstract][Full Text] [Related]
9. Molecular imaging of bone marrow mononuclear cell survival and homing in murine peripheral artery disease.
van der Bogt KE; Hellingman AA; Lijkwan MA; Bos EJ; de Vries MR; van Rappard JR; Fischbein MP; Quax PH; Robbins RC; Hamming JF; Wu JC
JACC Cardiovasc Imaging; 2012 Jan; 5(1):46-55. PubMed ID: 22239892
[TBL] [Abstract][Full Text] [Related]
10. Comparison of subcutaneous and intraperitoneal injection of D-luciferin for in vivo bioluminescence imaging.
Inoue Y; Kiryu S; Izawa K; Watanabe M; Tojo A; Ohtomo K
Eur J Nucl Med Mol Imaging; 2009 May; 36(5):771-9. PubMed ID: 19096841
[TBL] [Abstract][Full Text] [Related]
11. Dual reporter gene imaging for tracking macrophage migration using the human sodium iodide symporter and an enhanced firefly luciferase in a murine inflammation model.
Lee HW; Jeon YH; Hwang MH; Kim JE; Park TI; Ha JH; Lee SW; Ahn BC; Lee J
Mol Imaging Biol; 2013 Dec; 15(6):703-12. PubMed ID: 23677652
[TBL] [Abstract][Full Text] [Related]
12. Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice.
Kim S; Zhang Y; Tang S; Qin C; Karelia D; Sharma A; Jiang C; Lu J
Prostate; 2019 Jun; 79(9):949-960. PubMed ID: 30958914
[TBL] [Abstract][Full Text] [Related]
13. In vivo bioluminescence imaging.
Sato A; Klaunberg B; Tolwani R
Comp Med; 2004 Dec; 54(6):631-4. PubMed ID: 15679260
[TBL] [Abstract][Full Text] [Related]
14. Uptake kinetics and biodistribution of 14C-D-luciferin--a radiolabeled substrate for the firefly luciferase catalyzed bioluminescence reaction: impact on bioluminescence based reporter gene imaging.
Berger F; Paulmurugan R; Bhaumik S; Gambhir SS
Eur J Nucl Med Mol Imaging; 2008 Dec; 35(12):2275-85. PubMed ID: 18661130
[TBL] [Abstract][Full Text] [Related]
15. A luciferin analogue generating near-infrared bioluminescence achieves highly sensitive deep-tissue imaging.
Kuchimaru T; Iwano S; Kiyama M; Mitsumata S; Kadonosono T; Niwa H; Maki S; Kizaka-Kondoh S
Nat Commun; 2016 Jun; 7():11856. PubMed ID: 27297211
[TBL] [Abstract][Full Text] [Related]
16. A novel model of intracranial meningioma in mice using luciferase-expressing meningioma cells. Laboratory investigation.
Ragel BT; Elam IL; Gillespie DL; Flynn JR; Kelly DA; Mabey D; Feng H; Couldwell WT; Jensen RL
J Neurosurg; 2008 Feb; 108(2):304-10. PubMed ID: 18240927
[TBL] [Abstract][Full Text] [Related]
17. Rat model of metastatic breast cancer monitored by MRI at 3 tesla and bioluminescence imaging with histological correlation.
Song HT; Jordan EK; Lewis BK; Liu W; Ganjei J; Klaunberg B; Despres D; Palmieri D; Frank JA
J Transl Med; 2009 Oct; 7():88. PubMed ID: 19840404
[TBL] [Abstract][Full Text] [Related]
18. Factors Influencing Luciferase-Based Bioluminescent Imaging in Preclinical Models of Brain Tumor.
Kim M; Gupta SK; Zhang W; Talele S; Mohammad AS; Laramy J; Mladek AC; Zhang S; Sarkaria JN; Elmquist WF
Drug Metab Dispos; 2022 Mar; 50(3):277-286. PubMed ID: 34887255
[TBL] [Abstract][Full Text] [Related]
19. Dual-modality monitoring of tumor response to cyclophosphamide therapy in mice with bioluminescence imaging and small-animal positron emission tomography.
Ma X; Liu Z; Yang X; Gao Q; Zhu S; Qin C; Liu K; Zhang B; Han D; Wang F; Tian J
Mol Imaging; 2011 Aug; 10(4):278-83. PubMed ID: 21501569
[TBL] [Abstract][Full Text] [Related]
20. Non-invasive visualisation of the development of peritoneal carcinomatosis and tumour regression after 213Bi-radioimmunotherapy using bioluminescence imaging.
Buchhorn HM; Seidl C; Beck R; Saur D; Apostolidis C; Morgenstern A; Schwaiger M; Senekowitsch-Schmidtke R
Eur J Nucl Med Mol Imaging; 2007 Jun; 34(6):841-9. PubMed ID: 17206415
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
